Product Description — BPC-157 (BPC15)

Product Name: BPC-157 (Body Protection Compound 157)
CAS Number: 137525-51-0 Wikipedia+2PubChem+2
Alternate Names / Synonyms: BPC 157, BPC15, PL 14736, gastric pentadecapeptide, “Body Protection Compound”

Overview

BPC-157 is a synthetic 15-amino acid peptide (pentadecapeptide) derived from a fragment of a larger gastric peptide. Gut N’ Liver+3MDPI+3ResearchGate+3 It is sometimes referred to in the literature as BPC15 or Body Protection Compound. Frontiers+1

Although it is not approved by the U.S. Food and Drug Administration (FDA) for therapeutic use, BPC-157 appears in the public domain as a research peptide and is often marketed for investigational, cosmetic, or laboratory use only. Wikipedia+4precisionFDA+4Frontiers+4

Chemical & Physical Properties

Mechanism & Preclinical Evidence (Summary)

Important caveat: The following information is drawn from preclinical / in vitro / animal studies, and does not establish approved clinical use or safety in humans.

• BPC-157 has been studied for its cytoprotective, tissue-repair, angiogenic, and anti-inflammatory potential in various preclinical models. PMC+4MDPI+4Gut N’ Liver+4

• In tendon fibroblasts, BPC-157 has been shown to upregulate growth hormone receptor expression, possibly amplifying growth hormone–driven proliferation and repair pathways. PMC

• In musculoskeletal injury models, some studies report improved structural and functional outcomes in tendon, ligament, bone, and muscle after BPC-157 administration. Gut N’ Liver+3PMC+3MDPI+3

• Pharmacokinetic studies in rats and dogs suggest rapid elimination (half-life < 30 min) and metabolism to small peptide fragments, with excretion via urine and bile. Frontiers

• No major toxicity was observed in the animal models used, but clinical safety in humans remains unestablished. PMC+2Frontiers+2

Permissible (Regulation-Safe) Claims & Statements

To maintain compliance and avoid unapproved claims, you may include statements such as:

• “For research use only (not for human or veterinary use).”

• “This product is not an FDA-approved drug.”

• “Intended for laboratory, experiment, or in vitro / animal research applications.”

• “No claims are made that this product treats, cures, or prevents any disease.”

BPC-157 (CAS 137525-51-0) – Research Peptide / Investigational Use

BPC-157 (also known as BPC 15 or Body Protection Compound 157) is a synthetic pentadecapeptide derived from a fragment of a gastric peptide. With molecular weight ~1,419.56 Da (C₆₂H₉₈N₁₆O₂₂), it is often used in in vitro and in vivo research settings to explore its reported cytoprotective, angiogenic, and tissue repair properties (preclinical evidence only).

It is important to emphasize: this product is for research use only, and is not an FDA-approved drug or supplement for human or veterinary use. No claims are made regarding treatment, prevention, or diagnosis of disease.

Key Features & Notes

• CAS No.: 137525-51-0 (free base) PubChem+2Wikipedia+2

• Appearance: white to off-white lyophilized powder ResearchGate+3usbio.net+3ChemicalBook+3

• Stability: Resistant to certain enzymatic degradation; proper storage (cold, dry) recommended

• Pharmacokinetics (animal studies): Rapid clearance (t₁/₂ < 30 min), metabolism to small fragments, excretion via urine/bile Frontiers

• Study Use: Investigations into tissue repair, angiogenesis, anti-inflammatory response, tendon/ligament models, etc. (preclinical)

Storage & Handling
Store in a desiccated, cold environment (e.g., –20 °C or lower). Reconstitute under sterile conditions. Protect from repeated freeze–thaw cycles.

Suggested References / Links to Medical Literature

Here are some primary studies and review articles you can link to (or cite) to support the description:

1. “Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound BPC157” — He et al., Frontiers in Pharmacology, 2022. Frontiers

2. “Emerging Use of BPC-157 in Orthopaedic Sports Medicine” — Vasireddi et al. (systematic review) PMC

3. “Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts” — Chang et al. PMC+1

4. “Multifunctionality and Possible Medical Application of the BPC 157 Peptide” (Review & Patent Review) MDPI+1

5. “Stable Gastric Pentadecapeptide BPC 157, Robert’s cytoprotection concept” — review in Gut and Liver journal Gut N’ Liver

You can embed these as links in your product page or PDF as “Further Reading / References.”

• FOR RESEARCH USE ONLY